Literature DB >> 6279410

Calcium channel blockers: a pathophysiologically based antihypertensive treatment concept for the future?

F R Bühler, L Hulthén.   

Abstract

Mesh：

Substances：

Year:  1982        PMID： 6279410     DOI： 10.1111/j.1365-2362.1982.tb00930.x

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN： 0014-2972            Impact factor:   4.686


× No keyword cloud information.
  6 in total

Review 1.  Drug therapy of renovascular hypertension.

Authors:  Talma Rosenthal
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

2.  [Increase in liver circulation with nifedipine].

Authors:  J Nitsch; R Kuhnen; B Lüderitz
Journal:  Klin Wochenschr       Date:  1986-10-31

3.  Renal effects of felodipine in hypertensive patients with reduced renal function.

Authors:  H Herlitz; M Aurell; S Björck; G Granérus
Journal:  Drugs       Date:  1985       Impact factor: 9.546

4.  Effect of a new calcium antagonist, tiapamil, in hypertension of the elderly.

Authors:  P Balansard; F Elkik; J A Levenson; M Ciampi; P Sans
Journal:  Br J Clin Pharmacol       Date:  1984-12       Impact factor: 4.335

Review 5.  Platelet abnormalities and the pathophysiology of essential hypertension.

Authors:  F R Bühler; T J Resink
Journal:  Experientia       Date:  1988-02-15

6.  Calcium-channel blockade (nitrendipine) in combination with ACE inhibition (captopril) in the treatment of mild to moderate hypertension.

Authors:  C Gennari; R Nami; G Pavese; S Gragnani; C Bianchini; P Buracchi
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.